Abstract
Control of hepatitis C virus infection (HCV) is an increasingly important issue. Enhancing screening coverage is necessary to discover more HCV infected subjects in community. However, a substantial population is unaware of HCV infection that needs more attention. The aims of this study were to evaluate the status of HCV infected residents in remote villages, to compare characteristics between already known and unaware HCV infection subjects, and to analyze the disease insights. Screening intervention for liver diseases was conducted in remote villages of Tainan City of southern Taiwan from August 2014 to July 2016. Items of screening examinations included questionnaire, blood sampling for liver tests and viral hepatitis markers (hepatitis B surface antigen and anti-HCV antibody), abdominal sonography survey, and liver stiffness measurement by transient elastography. Quantitation of HCV RNA was measured for residents with positive anti-HCV antibody. A total of 194 (13.5%) out of 1439 participants showed positive for anti-HCV antibody. HCV viremia was detected in 119 (61.3%) residents. Previously unaware HCV infection by questionnaire record was present in 68 (35.1%) of ant-HCV positive residents. By multivariate logistic analys...Continue Reading
References
Mar 22, 1997·Lancet·T PoynardP Opolon
Dec 4, 2003·Journal of Internal Medicine·M DaltonUNKNOWN AusDiab Steering Committee
Mar 16, 2005·American Journal of Preventive Medicine·Linda HillUNKNOWN Prevention Practice Committee, American College of Preventive Medicine
Mar 7, 2007·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Chien-Hung ChenJin-Chuan Sheu
Sep 27, 2007·The American Journal of Gastroenterology·Masahide HamaguchiTakeshi Okanoue
Jun 20, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hla-Hla TheinMurray D Krahn
Dec 17, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Sarah L GeorgeAdrian M Di Bisceglie
Jun 22, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Timothy R MorganUNKNOWN HALT-C Trial Group
Sep 15, 2010·The Kaohsiung Journal of Medical Sciences·Jeng-Fu YangWen-Yu Chang
Apr 14, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Eric TrépoChristophe Moreno
Jan 11, 2013·Liver International : Official Journal of the International Association for the Study of the Liver·Liesl M Hagan, Raymond F Schinazi
Aug 3, 2014·Journal of Hepatology·Erin GowerHomie Razavi
Dec 3, 2014·Journal of Hepatology·Rachel H Westbrook, Geoffrey Dusheiko
Apr 17, 2015·Addiction·Teresa C PrevostDaniela De Angelis
May 15, 2015·PloS One·Yuan-Hung KuoSheng-Nan Lu
Sep 1, 2015·Gastroenterology·Francesco NegroMichael P Manns
Sep 10, 2015·PloS One·Nobuharu TamakiNamiki Izumi
Mar 26, 2016·Medicine·Pin-Nan ChengShih-Chieh Chien
Apr 20, 2016·Journal of Hepatology·Sven M FrancqueWilhelmus J Kwanten
Jul 12, 2017·Alimentary Pharmacology & Therapeutics·M P CurryN H Afdhal
Jul 29, 2017·Open Forum Infectious Diseases·Mariana CastrejónJeffrey D Klausner
Citations
Jan 31, 2020·Journal of Viral Hepatitis·Rosaida Md SaidMuhammad Radzi Abu Hassan
Aug 25, 2019·Journal of Gastroenterology and Hepatology·Jyh-Jou ChenPin-Nan Cheng
Aug 9, 2020·Hepatology Communications·Yun-Yuan ChenPei-Jer Chen
Oct 9, 2020·BMC Infectious Diseases·Wei LiMei-Yen Chen
May 7, 2021·PloS One·Chun-Yuan LeePo-Liang Lu